Chubb Corp’s AstraZeneca AZN Stock Holding History

Chubb Corp’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$23.8M	Hold	350,000	–	–	1.92%	18
2015 Q3	$22.3M	Hold	350,000	–	–	1.29%	29
2015 Q2	$22.3M	Hold	350,000	–	–	1.16%	32
2015 Q1	$23.9M	Hold	350,000	–	–	1.24%	30
2014 Q4	$24.6M	Hold	350,000	–	–	1.29%	27
2014 Q3	$25M	Hold	350,000	–	–	1.36%	16
2014 Q2	$26M	Hold	350,000	–	–	1.35%	17
2014 Q1	$22.7M	Hold	350,000	–	–	1.25%	20
2013 Q4	$20.8M	Hold	350,000	–	–	1.16%	33
2013 Q3	$18.2M	Hold	350,000	–	–	1.01%	45
2013 Q2	$16.6M	Buy	+350,000	New	+$17.8M	0.91%	47

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.3B AUM 24.77% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

SCCM

Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Chubb Corp's AZN Position: Q4 2015 in Review

Chubb Corp held its AstraZeneca (AZN) position steady in Q4 2015 at 350,000 shares worth $23.8M. The position accounts for 1.92% of the portfolio, ranked #18.

Chubb Corp first reported a position in AZN in Q2 2013 and has held it in 11 quarters since. The position peaked at $26M in Q2 2014. 390 funds tracked by Wall St. Rank hold AZN as of Q4 2015.

Chubb Corp held 350,000 shares of AstraZeneca worth $23.8M as of Q4 2015.
Chubb Corp left its AstraZeneca share count unchanged in Q4 2015.
AstraZeneca made up 1.92% of Chubb Corp's portfolio in Q4 2015, its #18 holding.
Chubb Corp first reported a position in AstraZeneca in Q2 2013 and has held it in 11 quarters since.
Chubb Corp's AstraZeneca position peaked at $26M in Q2 2014.
390 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2015.

Based on Chubb Corp's 13F filing for Q4 2015, filed 11 Feb 2016.